Lumos needs to update it's website. The 'Leadership Team' is showing Sam Lanyon in the role of 'Executive Chair and interim CEO', and Rob Sambursky as 'President and CEO'.
Also interesting they have a 'Chief Technology Officer', 'Senior Vice President of Corporate Strategy and Development', 'Senior Director of Medical Affairs' and 'Senior Director of Regulatory Affairs'.
Lumos is not Pfizer. What have all these people been doing? I would have thought a number of those roles would be performed by the CEO.
I'm pleased about the appointment of Doug Ward, it was much needed IMO.
Also interesting to note that Lumos Diagnostics has 5.5k followers on LinkedIn. That struck me as being surprisingly high. It would seem there's a bit of interest out there, in what Lumos is doing.
Ann: FDA Decision for FebriDx, page-75
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
-0.001(2.33%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.3¢ | 3.9¢ | $100.6K | 2.492M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 623990 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 298309 | 4 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| LDX (ASX) Chart |